Characteristics of clinical drugs for elderly chronic heart failure complicated with different degrees of renal insufficiency

被引:6
作者
Yu, Hepeng [1 ]
Chang, Jing [1 ]
Zhong, Wenwen [1 ]
Ye, Ping [1 ]
机构
[1] Chinese Peoples Liberat Army Gen Hosp, Beijing 100853, Peoples R China
关键词
Elderly; Heart failure; Chronic; Renal insufficiency; Treatment; Drug; DYSFUNCTION; COMMUNITY; ADULTS;
D O I
10.12669/pjms.341.13600
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To investigate the characteristics of clinical therapeutic drugs in elderly chronic heart failure (CHF) patients complicated with different degrees of renal insufficiency. Methods: The elderly patients who were hospitalized from October 2010 to October 2015 in our hospital due to CHF for the first time were selected by means of retrospective case collection. The glomerular filtration rate was estimated by using the Modification of Diet in Renal Disease (MDRD) Study equation. The patients were divided into a group with normal renal function, a group with slight decrease in renal function, and a group with moderate and severe decrease in renal function. Statistical analysis was made to compare the characteristics of clinical drugs for the three groups. Results: Compared with the normal renal function group and the slight decrease group, ACEIs and beta-blockers were less used in the moderate and severe decrease group, but diuretics and spironolactone were more used (P < 0.05). Compared with the normal renal function group, the use rate of ACEIs was low whereas that of diuretics was high (P < 0.05). Conclusion: ACEIs and beta-blockers were barely employed to treat elderly CHF patients complicated with renal insufficiency, but diuretics and spironolactone were frequently utilized.
引用
收藏
页码:135 / 138
页数:4
相关论文
共 10 条
[1]   Prevalence and significance of unrecognized renal insufficiency in patients with heart failure [J].
Amsalem, Yoram ;
Garty, Moshe ;
Schwartz, Roseline ;
Sandach, Amir ;
Behar, Solomon ;
Caspi, Abraham ;
Gottlieb, Shmuel ;
Ezra, David ;
Lewis, Basil S. ;
Leor, Jonathan .
EUROPEAN HEART JOURNAL, 2008, 29 (08) :1029-1036
[2]  
[全国eGFR课题协作组 Chinese eGFR Investigation Collaboration], 2006, [中华肾脏病杂志, Chinese Journal of Nephrology], V22, P589
[3]   The diagnosis of heart failure in the community - Comparative validation of four sets of criteria in unselected older adults: The ICARe Dicomano study [J].
Di Bari, M ;
Pozzi, C ;
Cavallini, MC ;
Innocenti, F ;
Baldereschi, G ;
De Alfieri, W ;
Antonini, E ;
Pini, R ;
Masotti, G ;
Marchionni, N .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 44 (08) :1601-1608
[4]   Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure - The anemia in chronic heart failure: Outcomes and Resource Utilization (ANCHOR) Study [J].
Go, Alan S. ;
Yang, Jingrong ;
Ackerson, Lynn M. ;
Lepper, Krista ;
Robbins, Sean ;
Massie, Barry M. ;
Shlipak, Michael G. .
CIRCULATION, 2006, 113 (23) :2713-2723
[5]   BG9719 (CVT-124), an A1 adenosine receptor antagonist, protects against the decline in renal function observed with diuretic therapy [J].
Gottlieb, SS ;
Brater, DC ;
Thomas, I ;
Havranek, E ;
Bourge, R ;
Goldman, S ;
Dyer, F ;
Gomez, M ;
Bennett, D ;
Ticho, B ;
Beckman, E ;
Abraham, WT .
CIRCULATION, 2002, 105 (11) :1348-1353
[6]   Efficacy and safety of benazepril for advanced chronic renal insufficiency [J].
Hou, FF ;
Zhang, X ;
Zhang, GH ;
Xie, D ;
Chen, PY ;
Zhang, WR ;
Jiang, JP ;
Liang, M ;
Wang, GB ;
Liu, ZR ;
Geng, RW .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (02) :131-140
[7]   Burden of systolic and diastolic ventricular dysfunction in the community - Appreciating the scope of the heart failure epidemic [J].
Redfield, MM ;
Jacobsen, SJ ;
Burnett, JC ;
Mahoney, DW ;
Bailey, KR ;
Rodeheffer, RJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (02) :194-202
[8]  
SWEDBERG K, 1987, NEW ENGL J MED, V316, P1429
[9]   Aggravated renal dysfunction during intensive therapy for advanced chronic heart failure [J].
Weinfeld, MS ;
Chertow, GM ;
Stevenson, LW .
AMERICAN HEART JOURNAL, 1999, 138 (02) :285-290
[10]   Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction:: the CHARM-Preserved Trial [J].
Yusuf, S ;
Pfeffer, MA ;
Swedberg, K ;
Granger, CB ;
Held, P ;
McMurray, JJV ;
Michelson, EL ;
Olofsson, B ;
Östergren, J .
LANCET, 2003, 362 (9386) :777-781